Navigation Links
Ocera Therapeutics receives CE Mark for Zysa™ for the treatment of diarrhea-predominant Irritable Bowel Syndrome (IBS-d)
Date:5/18/2012

al carbon adsorbent with a selective adsorption profile for a variety of substances linked to IBS-d. Zysa also adsorbs other substances including ammonia, indoles (serotonin), histamine, bile acids, advanced glycation endproducts (AGE), and certain bacterial toxins. Ocera licensed the compound from Kureha Corporation (Japan). Zysa has been used chronically by over 360,000 patients and studied in over 3,000 patients worldwide. It is marketed as Kremezin™ in Asia.

About Ocera Therapeutics, Inc.
Ocera Therapeutics, based in San Diego, California, USA, is a privately-held biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat liver diseases and gastrointestinal disorders.  In addition to Zysa™ (spherical carbon adsorbent), Ocera is developing OCR-002, an ammonia detoxification agent, for the treatment of patients with hepatic encephalopathy and acute liver failure. Ocera has raised over $60 million in financing from Domain Associates, Sofinnova Ventures, Thomas, McNerney & Partners, Greenspring Global Partners and InterWest Partners. Additional information on the company can be found at www.oceratherapeutics.com.


'/>"/>
SOURCE Ocera Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Services Industry (U.S.): Analytics, Extensive Financial ... 2021, NAIC 541380 ... Testing Laboratories, Safety and Compliance Services ...
(Date:8/28/2014)... Reportlinker.com announces that a new market ... Germany Aesthetic Lasers and Energy Devices Market ... Germany Aesthetic Lasers and Energy ... GlobalData,s new report, "Germany Aesthetic Lasers and Energy ... data on the Germany Aesthetic Lasers and Energy ...
(Date:8/28/2014)... 2014  Decision Resources Group finds that the ... through 2022 at a compound annual growth rate ... supported by strong population growth and a growing ... procedures. The Indian government,s greater investment in health ... or upgrade diagnostic imaging equipment. Other ...
Breaking Medicine Technology:Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3
... Technologies, Inc. (NMT), an award-winning company engaged in pioneering ... it has been awarded ISO 13485 certification of its ... safe and effective medical devices. This certification represents ... and sell NMT products in the European Union and ...
... recently honored by two transportation trade associations with national ... Department. The Company received the American Trucking Association,s ... Miles" category. In addition, the National Private Truck ... CVS/pharmacy,s Knoxville, TN distribution center as one of its ...
Cached Medicine Technology:Noninvasive Medical Technologies Awarded ISO 13485 Quality Certification 2CVS/pharmacy's Transportation Operations Receives Two National Safety Awards 2
(Date:8/29/2014)... 29, 2014 Evolutions Medical & Day ... the Santa Barbara News-Press Readers’ Choice 2014 poll. This ... Choice poll as Best Medical Spa. The 2014 Readers’ ... following about Evolutions Medical Spa recognition: , “Not only ... recognized as a top-notch, cutting-edge medical spa as well. ...
(Date:8/29/2014)... India (PRWEB) August 29, 2014 RBS Reputation ... Remove Scam Book. The service is to help those ... reviews against them on Scam Book. The service would push ... and make Scam Book complaints fully invisible on Google. ... service. , On being asked how company can provide ...
(Date:8/29/2014)... A home should be a safe haven, but there ... Amica Insurance is sharing some tips to help improve safety in ... following safety measures: , Kitchen, , Store hazardous ... and keep them away from food. , ... , Bathroom , Put slip-resistant ...
(Date:8/29/2014)... outbreaks across the Arabian Peninsula and spread to Europe ... lives of several hundred people since its discovery in ... over how easily the pathogen spreads from human to ... from the University of Bonn have now come to ... human transmission is low. Still, a third of infected ...
(Date:8/29/2014)... Glendale Botox experts at Glenoaks Laser Center ... month of September. This special offer features 10 free units ... Patients can take advantage of this special offer to completely ... will work with patients to determine if Botox or Juvederm ... , Botox is a treatment made from the botulinum ...
Breaking Medicine News(10 mins):Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3Health News:RBS Reputation Management Announces a New Online Reputation Management Service 2Health News:Improve Home Safety with Tips from Amica Insurance 2Health News:MERS: Low transmissibility, dangerous illness 2Health News:MERS: Low transmissibility, dangerous illness 3Health News:Glenoaks Laser Center is Now Offering a Special Promotion on Botox for the Month of September 2
... , , SCHAUMBURG, Ill., Sept. ... American Veterinary Medical Association (AVMA) reveal an economic mixed bag when ... , The survey results appear in the ... 1, 2009, article entitled, "Employment, starting salaries, and educational indebtedness of ...
... , SHANGHAI, Sept. 1 /PRNewswire-Asia/ ... manufacturer and distributor,of healthcare-related disinfectants in China, put forward ... with the spread of H1N1. , ... to prevent and control,infectious diseases, and it will work ...
... HAIKOU CITY, China, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China ... and markets specialty pharmaceutical products in China, today,announced it will ... -- Rodman & Renshaw Annual Global Investment Conference, held September, ... New York Palace Hotel in New York City. Management, ...
... BARCELONA, Spain, Sept. 1 New data ... (pitavastatin), high-density lipoprotein cholesterol (HDL-C) concentrations increased, and nearly ... with results sustained over 52 weeks. Additionally, LIVALO was ... as measured by reduction in LDL-C from baseline. The ...
... , , ... largest and most trusted source for online care, announced today that it ... which secured $7.5 million in financing in January of this year, opened ... leaders in Chicago,s investment community. , , ...
... Officials expect return of virus that first surfaced last spring ... H1N1 swine flu break out on U.S. college campuses, school ... preventative steps to keep the virus from spreading further. ... young people, who are often the least likely to take ...
Cached Medicine News:Health News:AVMA Survey Indicates Most Starting Salaries Are Up for New Veterinarians 2Health News:AVMA Survey Indicates Most Starting Salaries Are Up for New Veterinarians 3Health News:Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine? 2Health News:Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine? 3Health News:China Pharma Holdings, Inc. Announces Participation in September Conferences 2Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 2Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 3Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 4Health News:LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 5Health News:Growth Attracts Additional Investors to Sittercity.com 2Health News:Swine Flu on Campuses Boosts Call for Vaccinations 2
... (CDN) closed dilution nebulizer allows the clinician to ... additional gas into the side port for precise ... ,The P31000N, for normal flow patients, delivers 8-12 ... in the side port. For your high flow ...
Rotary Piston Mini Nebulizer...
... is a disposable lighting system that provides ... and deep surgical incisions. The system features ... light rod designed to illuminate the tip ... The system can be connected to existing ...
... HELION family consists of four models in ... - to ensure you find the right ... singly or in a combination of two ... the standard design with an on/off switch ...
Medicine Products: